IO Biotech, Inc.
IOBT
$0.64
$0.011.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.61M | 6.52M | 6.21M | 5.80M | 6.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.36M | 23.17M | 22.58M | 26.94M | 26.50M |
| Operating Income | -19.36M | -23.17M | -22.58M | -26.94M | -26.50M |
| Income Before Tax | -10.04M | -26.10M | -22.28M | -30.89M | -23.81M |
| Income Tax Expenses | -1.66M | 118.00K | 146.00K | 445.00K | 209.00K |
| Earnings from Continuing Operations | -8.38M | -26.22M | -22.42M | -31.33M | -24.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.38M | -26.22M | -22.42M | -31.33M | -24.02M |
| EBIT | -19.36M | -23.17M | -22.58M | -26.94M | -26.50M |
| EBITDA | -19.29M | -23.11M | -22.52M | -26.88M | -26.44M |
| EPS Basic | -0.13 | -0.40 | -0.34 | -0.48 | -0.36 |
| Normalized Basic EPS | -0.09 | -0.25 | -0.21 | -0.29 | -0.23 |
| EPS Diluted | -0.13 | -0.40 | -0.34 | -0.48 | -0.36 |
| Normalized Diluted EPS | -0.09 | -0.25 | -0.21 | -0.29 | -0.23 |
| Average Basic Shares Outstanding | 66.94M | 65.88M | 65.88M | 65.88M | 65.88M |
| Average Diluted Shares Outstanding | 66.94M | 65.88M | 65.88M | 65.88M | 65.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |